1-5 of 5
Neil H. Segal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4380: Integrative genomics analysis of metastatic colorectal cancer

Marla Lipsyc, Walid Chatila, Jaclyn F. Hechtman, Francisco Sanchez-Vega, Sumit Middha, Andrea Cercek, Zsofia Stadler, Ritika Kundra, Aijazuddin Syed, David M. Hyman, Ahmet Zehir, Armin Shahrokni, Anna Varghese, Diane Reidy, Neil H. Segal, Efsevia Vakiani, David B. Solit, Marc Ladanyi, Michael F. Berger, Nancy Kemeny, Leonard Saltz, Nikolaus Schultz, Rona Yaeger
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4380.
https://doi.org/10.1158/1538-7445.AM2017-4380
Published: 01 July 2017
View article titled, Abstract 4380: Integrative genomics analysis of metastatic colorectal cancer
Journal Articles

Abstract CT211: IMMU-130, an SN-38 antibody-drug conjugate (ADC) targeting CEACAM5, is therapeutically active in metastatic colorectal cancer (mCRC): Initial clinical results of two Phase I studies

Neil H. Segal, Efrat Dotan, Jordan D. Berlin, Alexander N. Starodub, Michael J. Guarino, Leonard B. Saltz, Pius P. Maliakal, Serengulam V. Govindan, William A. Wegener, Robert M. Sharkey, David M. Goldenberg
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): CT211.
https://doi.org/10.1158/1538-7445.AM2014-CT211
Published: 01 October 2014
View article titled, Abstract CT211: IMMU-130, an SN-38 antibody-drug conjugate (ADC) targeting CEACAM5, is therapeutically active in metastatic colorectal cancer (mCRC): Initial clinical results of two Phase I studies
Journal Articles

Abstract LB-159: A Phase I study of IMMU-130 (labetuzumab-SN38) anti-CEACAM5 antibody-drug conjugate (ADC) in patients with metastatic colorectal cancer (mCRC).

Neil H. Segal, Jaclyn Verghis, Serengulam Govindan, Pius Maliakal, Robert M. Sharkey, William A. Wegener, David M. Goldenberg, Leonard B. Saltz
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): LB-159.
https://doi.org/10.1158/1538-7445.AM2013-LB-159
Published: 15 April 2013
View article titled, Abstract LB-159: A Phase I study of IMMU-130 (labetuzumab-SN38) anti-CEACAM5 antibody-drug conjugate (ADC) in patients with metastatic colorectal cancer (mCRC).
Journal Articles

Epitope Landscape in Breast and Colorectal Cancer

Neil H. Segal, D. Williams Parsons, Karl S. Peggs, Victor Velculescu, Ken W. Kinzler, Bert Vogelstein, James P. Allison
Journal: Cancer Research
Cancer Res (2008) 68 (3): 889–892.
https://doi.org/10.1158/0008-5472.CAN-07-3095
Published: 01 February 2008
View article titled, Epitope Landscape in Breast and Colorectal Cancer
Open the PDF for Epitope Landscape in Breast and Colorectal Cancer in another window
Journal Articles

Analysis of Hypoxia-Related Gene Expression in Sarcomas and Effect of Hypoxia on RNA Interference of Vascular Endothelial Cell Growth Factor A

Kara Y. Detwiller, Namali T. Fernando, Neil H. Segal, Sandra W. Ryeom, Patricia A. D'Amore, Sam S. Yoon
Journal: Cancer Research
Cancer Res (2005) 65 (13): 5881–5889.
https://doi.org/10.1158/0008-5472.CAN-04-4078
Published: 01 July 2005
View article titled, Analysis of Hypoxia-Related Gene Expression in Sarcomas and Effect of Hypoxia on RNA Interference of Vascular Endothelial Cell Growth Factor A
Open the PDF for Analysis of Hypoxia-Related Gene Expression in Sarcomas and Effect of Hypoxia on RNA Interference of Vascular Endothelial Cell Growth Factor A in another window